Analyst Confidence Strong in Annexon (ANNX) Amid Vonaprument Advancement [Yahoo! Finance]
Annexon: Maintaining "Buy" Rating On Second C1q Inhibitor Advancement For Geographic Atrophy [Seeking Alpha]
Annexon stock rises after director purchases shares [Seeking Alpha]
Annexon (NASDAQ:ANNX) had its price target raised by analysts at Wells Fargo & Company from $14.00 to $27.00. They now have an "overweight" rating on the stock.
Annexon Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $86.25 Million [Yahoo! Finance]